The threat of drug-resistant bacteria continues to grow — and so does our commitment to helping you combat this global issue. As a
leader in diagnostics for more than 50 years, we have made it our mission to innovate and advocate for better antimicrobial stewardship.
Discover how Roche can help you bring insights and innovative solutions to your institution’s antimicrobial stewardship program.
Help determine if antibiotics are needed or if certain bacterial infections are resolving.
The Elecsys BRAHMS PCT solution aids in assessing the mortality risk of patients fighting sepsis and guiding antibiotic decision-making for patients with lower respiratory tract infections, like pneumonia, bronchitis, COPD and sepsis.5,6
Timely and cost-effective molecular solutions for improved HAI management
The cobas MRSA/SA and Cdiff tests provide provide excellent performance and broad coverage to increase confidence in HAI testing. Run on the fully automated cobas 4800 system, these assays may help your institution control infections and costs.
External links and resources to help you with your Antimicrobial Stewardship initiatives
* This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA.
** This product has been approved by FDA for use by authorized laboratories certified under CLIA to perform moderate complexity testing.
COBAS, LIAT, ELECSYS and VIEWICS are trademarks of Roche.
© 2022 Roche Diagnostics, North America. All rights reserved.